|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 9.355 CHF | -1.11% |
|
+0.43% | -4.08% |
| 08:22am | Santhera Pharmaceuticals Swings to Profit in FY23; Revenue Grows | MT |
| 07:00am | Santhera Pharmaceuticals Holding AG Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Santhera Pharmaceuticals Holding AG reported earnings results for the full year ended December 31, 2021. For the full year, the company reported negative sales was CHF 2.72 million compared to sales of CHF 13.41 million a year ago. Negative revenue was CHF 1.6 million compared to revenue of CHF 15.01 million a year ago.
Net loss was CHF 55.53 million compared to CHF 67.66 million a year ago. Basic loss per share from continuing operations was CHF 1.62 compared to CHF 5.08 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -4.08% | 95.38M | |
| +4.20% | 70.78B | |
| +10.72% | 9.15B | |
| -15.34% | 4.84B | |
| +34.54% | 4.22B | |
| +5.09% | 3.92B | |
| +21.43% | 2.55B | |
| -28.33% | 2.24B | |
| -24.15% | 2.26B | |
| +6.23% | 1.92B |
SANTHERA PHARMACEUTICALS HOLDING AG 
